Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis
The University of Sydney · St George Hospital · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
836
total citations
- FWCI
- 45.43
- Percentile
- 100%
- References
- 15
Citations per year
Authors
7- CKChee Khoon LeeCorresponding
The University of Sydney, St George Hospital, National Health and Medical Research Council
- JMJohnathan Man
St George Hospital
- SLSally Lord
The University of Sydney, National Health and Medical Research Council, The University of Notre Dame Australia
- MLMatthew Links
St George Hospital
- VGVal Gebski
The University of Sydney, National Health and Medical Research Council
Topics & keywords
Topics
Keywords
- Medicine
- Docetaxel
- Nivolumab
- Atezolizumab
- Pembrolizumab
- Oncology
- Hazard ratio
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.